Xianglin Mei

467 citations
22 papers · 309 indexed · h-index 8
Topics
Autoimmune Bullous Skin Diseases (2 papers)Cancer Cells and Metastasis (2 papers)Pluripotent Stem Cells Research (2 papers)
Partner nations
ChinaJapan

In The Last Decade

Xianglin Mei

21 papers receiving 307 citations

Peers

Xianglin Mei
Comparison fields: 5 of 76
  • Molecular Biology 115
  • Neurology 67
  • Oncology 45
  • Surgery 43
  • Critical Care and Intensive Care Medicine 37
Replace S. Sookhai with:
S. Sookhai Ireland
Adam Galle Australia
Kejian Qian China
Kristian‐Christos Ngamsri Germany
Bangwei Luo China
Ainhoa Alberro Spain
Munehiko Shibata Japan
Sipin Tan China
Lan-Fang Huang China
Xianglin Mei relative to S. Sookhai Ireland S. Sookhai's profile →
Citations per field
00.5×9.7×
S. Sookhai · 1×
Citations per year

Countries citing papers authored by Xianglin Mei

Since Specialization
Citations

This map shows the geographic impact of Xianglin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Mei more than expected).

Fields of papers citing papers by Xianglin Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Mei. The network helps show where Xianglin Mei may publish in the future.

Co-authorship network of co-authors of Xianglin Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglin Mei. A scholar is included among the top collaborators of Xianglin Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglin Mei. Xianglin Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 13
3 1
4 19
5 4
6 1
7 5
8 140
9 42
10 1
11 6
12 7
13 7
14 1
15
A huge mediastinal, well-differentiated liposarcoma with heterogenous smooth muscle differentiation: a case report.
2
16 16
17 5
18 7
19 10
20 4

About Xianglin Mei

Xianglin Mei is a scholar working on Aging, Applied Microbiology and Biotechnology and Nephrology, having authored 22 papers that have together received 309 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (2 papers), Cancer Cells and Metastasis (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Neurology (67 citations), Critical Care and Intensive Care Medicine (37 citations) and Biological Psychiatry (14 citations). Xianglin Mei has collaborated with scholars based in China and Japan. Frequent co-authors include Ming Gu, Yanan Zhao, Meiying Li, Lisha Li, Hongwen Gao, Jiayi Xu, Hironobu Sasano, Xia He, Yulin Li and Jiaxu Yang. Their work appears in journals such as Scientific Reports, Advanced Science and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026